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“As you set out for Ithaka 
hope the voyage is a long one, 
full of adventure, full of discovery. 
Laistrygonians and Cyclops, 
angry Poseidon—don’t be afraid of them: 
you’ll never find things like that on your way 
as long as you keep your thoughts raised high, 
as long as a rare excitement 
stirs your spirit and your body. 
 
Hope the voyage is a long one. 
May there be many a summer morning when, 
with what pleasure, what joy, 
you come into harbors seen for the first time; 
may you stop at Phoenician trading stations 
to buy fine things, 
and may you visit many Egyptian cities 
to gather stores of knowledge from their scholars. 
  
Keep Ithaka always in your mind. 
Arriving there is what you are destined for. 
But do not hurry the journey at all. 
Better if it lasts for years, 
so you are old by the time you reach the island, 
wealthy with all you have gained on the way, 
not expecting Ithaka to make you rich. 
  
Ithaka gave you the marvelous journey. 
Without her you would not have set out. 
She has nothing left to give you now. 
  
And if you find her poor, Ithaka won’t have fooled you. 
Wise as you will have become, so full of experience, 
you will have understood by then what these Ithakas mean” 
 
“Ithaka” by Constantine P. Cavafy 
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Resumo 
 
 
O desenvolvimento da infeção por micobactérias é caracterizado pela 
formação de granulomas, os quais são agregados bem organizados de células 
do sistema imunitário, nomeadamente macrófagos infetados. A principal 
função do granuloma é restringir e prevenir a disseminação da micobactéria 
permitindo que a resposta imunitária seja centrada numa área limitada. Por 
vezes, estas lesões aumentam em tamanho, progredindo para um processo de 
necrose central levando à caseação tecidular. Contudo, o mecanismo 
subjacente a este tipo de patologia é pouco compreendido. Tem sido descrito 
que a redução da vascularização dos granulomas é essencial para a sua 
caseação e alguns estudos demonstraram que o centro do granuloma é 
altamente hipóxico. Em condições de hipóxia as células do sistema imunitário 
necessitam de se adaptar rapidamente a concentrações de oxigénio baixas de 
forma a permanecerem funcionalmente ativas. Assim, o fator indutível por 
hipóxia – 1 alfa (HIF-1α) tem emergido como o principal regulador do sistema 
de adaptação à hipoxia, mediando uma série de mecanismos fisiológicos e 
celulares. O grupo de investigação da responsabilidade do Professor 
Appelberg, desenvolveu um modelo de estudo que mimetiza a necrose do 
granuloma observado durante a infeção por Mycobacterium tuberculosis em 
humanos. Este modelo consiste na infeção intravenosa de murganhos 
C57BL/6 com uma dose baixa de uma estirpe altamente virulenta de 
Mycobacterium avium (ATCC 25291). Estes murganhos desenvolvem 
granulomas necrosados após 4 meses de infeção. Para determinar a 
relevância do HIF-1α durante a infeção por M. avium, foram utilizados 
murganhos com células da linhagem mielóide deletadas para o fator HIF-1α 
sobre o controlo do sistema Cre-lox. Os resultados obtidos indicam que os 
murganhos deficientes em HIF-1α são mais suscetíveis à infeção e em que o 
aparecimento de granulomas necróticos é antecipado. 
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Abstract 
 
The establishment of mycobacterial infection is characterized by the formation 
of granulomas, which are well-organized aggregates of immune cells, namely 
infected macrophages. The granuloma main function is to constrain and 
prevent dissemination of the mycobacteria, while concentrating the immune 
response to a limited area. In some cases these lesions can grow progressively 
into large granulomas which can undergo central necrosis leading to their 
caseation. However, the mechanism underlying this type of pathology is still 
poorly understood. It has been reported that reduced vascularization of 
granulomas may be one essential mechanism for caseation and some studies 
have demonstrated severely hypoxic regions at the center of the granuloma. 
Under hypoxic conditions the immune cells need to adapt to low oxygen 
conditions in order to remain functionally active. Thus, the hypoxia-inducible 
factor – 1 alpha (HIF-1α) has emerged as a master regulator of the hypoxia 
adaptation system, mediating a wide range of physiological and cellular 
mechanisms. The Appelberg group has developed a granuloma necrosis model 
that mimics the human pathology of Mycobacterium tuberculosis, using 
C57BL/6 mice intravenously infected with a low dose of a highly virulent strain 
of Mycobacterium avium (ATCC 25291). Such mice develop granulomas that, 
at 4 months of infection, exhibit central necrosis. To determine the relevance of 
HIF-1α during M. avium infection we used a mouse strain deleted of HIF-1α 
under the Cre-lox system in the myeloid cell lineage. The results obtained 
indicate that HIF-1α deficient mice are more susceptible to the infection and 
that the onset of necrotic granulomas is faster. 
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1. Tuberculosis 
Tuberculosis (TB) has plagued humankind worldwide for thousands of years. Besides 
archaeological evidences that TB was already present in Egyptian mummies, the climax of 
the TB epidemic occurred during the end of the XVIII century and the beginning of the XIX 
century, by the time of industrial revolution. Living and working in manufactures cities was 
terrible due to the overcrowded dwellings where sanitation and hygiene were absent. No 
wonder that TB was responsible for up to 25% of deaths in Europe. In the beginning of the 
XX century, new cases of TB began to fall as living standards (housing, nutrition, and 
income) improved, just before the advent of antituberculosis drugs. Despite the discovery of 
antituberculosis drugs more than 60 years ago, TB still remains a major global health 
problem 1-3. In 2013, there were an estimated 9.0 million new cases of TB, and despite being 
in most instances, a curable disease, 1.5 million people died in 2013 due to TB. Although all 
countries are affected, 85% of cases occur in Africa (29%) and Asia (56%), while India and 
China alone represent 35% of TB cases (Fig. 1). TB is highly connected with the human 
immunodeficiency virus (HIV). People infected with HIV represent over 10% of annual TB 
cases and are up to 37 times more likely to develop TB than HIV-negative individuals 1, 4, 5. 
Figure 1 - Estimated TB incidence rates by country in 2013. Adapted from WHO 
1
(http://www.who.int/topics/tuberculosis/en/) 
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1.1. Epidemiology of M. tuberculosis 
TB disease is mainly caused by the slow-growing acid-fast bacillus Mycobacterium 
tuberculosis (M. tuberculosis), identified by the Nobel Prize laureate, Robert Koch in 1882. 
According to estimates by the World Health Organization (WHO), one-third of the world’s 
population is infected with M. tuberculosis, but remains asymptomatic and noninfectious– 
defined as latent TB. In 90% of the cases, the infection will not lead to active disease, while 
the other 10% will develop active disease in their lifetime 3, 4. The M. tuberculosis is primarily 
transmitted by the respiratory route, through the inhalation of aerosolized droplets that carry 
the bacteria. TB is predominantly a disease of the lung and for that reason pulmonary TB is 
the most common, accounting for 70% of the cases. However, it can cause disease in other 
organs, including lymph nodes, bone and meninges, thereby causing extra pulmonary 
disease 6, 7. 
 
1.2 Mycobacterium genus 
The genus Mycobacterium includes more than 150 species that reside in a wide 
variety of habitats 8. Among these species, the great majority are non-pathogenic 
environmental organisms, although this genus also contains important human pathogens. M. 
tuberculosis complex includes M. tuberculosis, M. africanum, M. canetti, M. bovis and M. 
microti, and these are all agents of TB, being the leading cause of death from a curable 
infectious disease in world. M. leprae and M. ulcerans are the causative agents of leprosy 
and buruli ulcers, respectively. These are, respectively, the second and third most common 
mycobacterial infections in humans, after TB 9, 10. However, while TB, leprosy and buruli 
ulcers are specific diseases caused by specific mycobacteria, other mycobacteria are usually 
referred simply as atypical mycobacteria or nontuberculosis mycobacteria (NTM). According 
to current taxonomy, the NTM include more than 90 known species, however, about one 
third has been associated with human and animal diseases. Among the NTM, the 
Mycobacterium avium complex (MAC) attracts serious attention. The MAC comprises a 
group of closely related species: Mycobacterium avium (M. avium) and M. intracellulare. 
MAC is probably the most common cause of disease from NTM in most regions of the world. 
MAC is extremely widespread in numerous environmental sources, including soil, residential 
and hospital water systems, public drinking and potable water sources 11, 12. In the last years 
of the 20th century, the M. avium infection became particularly relevant due to the close 
connection with the acquired immune deficiency syndrome (AIDS) patients. M. avium is an 
opportunistic infectious agent that mostly affects patients with underlying conditions that 
compromise immunity. In fact, M. avium is frequently found in AIDS patients. The HIV 
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infection leads to a progressive reduction of CD4+ T cells that is correlated with the 
increasing risk of M. avium infection. The patients with advanced HIV disease (CD4+ T cells 
count <50 cells/µL) have higher risk of developing M. avium infection. The risk does not 
appear to vary according to the gender, ethnicity or route of transmission 13, 14. 
 
1.3 Immune responses to mycobacterial infections 
1.3.1 Initial events following the mycobacterium infection 
In humans, the most common routes of infection by M. avium are either through the 
intestinal tract, causing rapidly disseminating infections, or by the inhalation of droplets 
containing the bacillus, which slowly disseminate to other organs. Following the 
establishment of pathogenic Mycobacterium spp (including M. avium) infection, the bacilli are 
phagocytosed mainly by resident macrophages but also by neutrophils and dendritic cells 
(DCs). After successfully infecting the host, the lifestyle of M. avium is identical to that of 
other pathogenic mycobacteria. This process triggers a pro-inflammatory and anti-
inflammatory response that induce the production of cytokines and chemokines, a stimulation 
of phagocyte antimicrobial activities and the recruitment of other cell types from neighboring 
blood vessels, which leads to the granuloma formation (which will be discussed later) 6, 7. As 
previously described, the bacteria enter the host, and three outcomes are possible: (i) the 
immune system immediately destroys the mycobacteria (rare); (ii) the balance between the 
immune responses and the bacteria growth leads to the formation of the granuloma, 
preventing the dissemination of the mycobacteria - latent state; (iii) the infection leads to 
disease (this frequently occurs in immunocompromised individuals) – active disease 15, 16. 
Despite the involvement of DCs and natural killer (NK) cells in the innate immune response 
against the mycobacteria infection, macrophages play the pivotal role in the resistance 
against the mycobacteria infection. 
 
1.3.2 Recognition of the mycobacteria by macrophages 
The immune system has the ability to detect and eliminate invading pathogenic 
microorganisms by discriminating between “self” and “non-self”. The innate immune system 
detects non-self through the pattern recognition receptors (PRR), which can recognize 
conserved molecular structures found in microbes. Therefore, phagocytosis of mycobacteria 
by macrophages is a prelude to microbial killing. The internalization of mycobacteria by 
macrophages is mediated by a diverse array of receptors: type A scavenger receptors, 
complement receptors (CR3 and CR4), mannose or Fcγ receptors. 
6 
Apart from phagocytosis, some data have also shown the importance of the 
recognition of M. avium via the Toll-like receptor (TLR) playing a key role in the innate 
immunity. So far, thirteen TLRs have been identified in humans, and each appears to be 
required for responses to a different class of infectious pathogen 17, 18. TLR-2 has been 
described as the main receptor for mycobacterial components 19. Wang et al, described that 
M. avium infection induces TLR-2 mRNA expression and decreases TLR-4 mRNA 
expression in macrophages 20. The analysis of TLR-2 deficient mice has shown an increase 
of susceptibility to M. avium compared with the C56BL/6 mice 21, 22. Interestingly, despite the 
clear involvement of TLR-2, mice deficient in myeloid differentiation factor 88 (MyD88), an 
intracellular adaptor protein that transduces signals from most TLR, are even more 
susceptible to M. avium than TLR-2 deficient mice 22. The highly enhanced susceptibility of 
animals deficient in MyD88 was indicative that multiple TLRs might be involved in the innate 
recognition of M. avium 23. 
 
1.3.3 Phagocytosis 
Upon mycobacteria internalization, a sequence of processes leads to the formation of 
cytoplasmic vacuoles called phagosomes, which encapsulate the engulfed bacteria. 
Normally, the phagosome maturation is a complex process that leads to the fusion of the 
phagosome with the lysosome, resulting in the phagolysosome. The lysosome is a complex 
vacuolar organelle that contains hydrolytic enzymes capable of degrading the phagocytized 
material in the phagolysosome structure 24. These enzymes are active at the optimally acidic 
pH (4.5 – 5.0) maintained within the lysosome, but not at the neutral pH of the cytosol 25. The 
lysosome is, in fact, the most acidic organelle in humans 26. The acidic environment results 
from the action of the membrane adenosine triphosphate (ATP)-dependent proton pumps, 
which actively transport protons into the lysosome from the cytosol 26, 27. However, viable and 
virulent mycobacteria have the ability to prevent phagosomal maturation, by inhibiting the 
phagosome-lysosome fusion 28, 29. Thus, through this mechanism mycobacteria can adapt to 
the intracellular environment of the macrophage, creating a niche for survival, which prevents 
the acidification of the phagocytic vacuole. The normal M. avium phagosomal environment is 
between pH = 5.8 to 6.1 and the pH optimal for M. avium survival is 6.0. This collectively 
suggests that the low acidic environment encountered by M. avium within macrophages 
favors its survival 25, 30. 
However, the activation of macrophages causes a dramatic increase in the resistance 
against M. avium, leading to the maturation of mycobacterial phagosomes 31-33. While 
unactivated macrophages have low microbicidal activity and express low levels of major 
histocompatibility complex (MHC) class II molecules, an activated macrophage shows 
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increased microbicidal activity through the improvement of killing mechanism and it is 
transformed into a potent antigen-presenting cell (APC) 33, 34. Infected macrophages can 
produce numerous cytokines, namely, tumor necrosis factor alpha (TNFα) and interleukin – 
12 (IL-12). These cytokines can act in concert to drive an interferon gamma (IFNγ) response 
from T helper type 1 (TH1) and NK cells. IFNγ plays a major role in the activation of 
macrophages 35. Several in vitro studies suggest that mycobacterial phagosomes are shifted 
from an early to a late endosomal stage of the phagosome maturation by macrophage 
activation, which is associated with a reduction in mycobacterial growth and viability 36, 37. 
Notably, experiments using IFNγ deficient mice showed an exacerbation of M. avium 
infection 38, 39. These findings suggest that resistance to mycobacteria requires the secretion 
of IFNγ, which leads to the activation of macrophages and consequently to the control of the 
infection. 
 
1.3.4 Killing mechanisms 
Among the antimicrobial mechanisms of the macrophage, those involving oxidative 
damage such as: the respiratory burst with production of reactive oxygen species (ROS) and 
nitric oxide (NO), have proven to be important mechanisms in the killing of many pathogens. 
In fact, these two systems act synergistically in killing many microbes. These mechanisms 
are considered the major players in the growth control of intracellular parasites. However, 
numerous studies highlighted the existence of antimicrobial activity, which is not dependent 
of NO and ROS generation. In fact, the use of p47phox (component of the NADPH oxidase) 
deficient mice, have shown that the respiratory burst is not required for the control of M. 
avium 40, 41. Doherty and Sher showed that inducible nitric oxide synthase (iNOS) deficient 
mice were resistant to M. avium infection 42 and that at later stages of infection they were 
even more resistant 43. With a similar approach, studies with Salmonella and Listeria using 
double knockout mice deficient in the generation of ROS and iNOS showed that 
macrophages were able to kill the bacteria 44. These findings suggest the existence of ROS 
and NOS-independent antimicrobial mechanisms. 
The deprivation of essential nutrients arises as a potential mechanism to limit 
intracellular growth of M. avium. Early studies on the genetics of susceptibility to infection 
highlighted the role of the gene natural resistance associated macrophage protein 1 
(Nramp1) or solute carrier family 11a member 1 (Slc11a1) in the control of M. avium infection 
in mice 40, 45. Nramp1 is a transmembrane protein expressed in endosomal and phagosomal 
membranes of macrophages, and has the ability to affect the capacity of the host to control 
intracellular replication, presumably by depriving the access to iron by the pathogen 46, 47. 
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Consequently, a strong dependence of the infection severity upon the presence of functional 
versus dysfunctional Nramp1 allele it has been demonstrated in mice 48, 49. 
 
1.3.5 Cytokines 
Cytokines are important mediators and regulators of the immune response against all 
pathogens. The interaction between the pathogens and cells of the immune system strongly 
induces the secretion of cytokines which are crucial in innate defense and in determining the 
subsequent adaptive response. In this section, the roles of various cytokines involved in the 
response to M. avium are discussed. 
IFNγ plays a key role in the control of M. avium infection. This cytokine is mainly 
produced by CD4+ T cells 50 and NK cells (Fig. 2). It is now known that the innate 
lymphocytes, γδ T cells, natural killer T cells (NKT) and CD8+ T cells can also produce IFNγ 
in response to mycobacterial stimulation. IFNγ plays a crucial role in the activation of 
macrophages, promoting the production of NO and other intermediates, that results in 
mycobacterial growth control. In fact, in vivo neutralization of IFNγ exacerbates M. avium 
infection 38, 39 and IFNγ deficient mice are more susceptible to the infection 42, 51. 
TNFα also plays a major role in the initial and long-term control of M. avium infection. 
M. avium induces TNFα secretion by macrophages, neutrophils, DCs and T cells. TNF is 
important in early response by activating macrophages (Fig. 2) as well as cell recruitment to 
the site of infection. The important role played by TNFα during M. avium infection was 
demonstrated through the exogenous administration of TNFα in vitro, which led to M. avium 
elimination 52, 53. In the other hand, the neutralization of TNFα led to exacerbation of M. 
avium54 and it was also shown that TNFα deficient mice succumbed to M. avium53, 55. 
IL-12 is induced in response to mycobacteria by macrophages and DCs. 
Subsequently, IL-12 stimulates the production of IFNγ by immune cells, in particular NK cells 
and helper T cells (Fig. 2) 56. The production of IFNγ has a very powerful effect in enhancing 
the ability of phagocytic cells to produce IL-12. This cytokine also enhances the production of 
IFNγ, creating a positive reinforcement loop 57. IL-12 also drives an adaptive cellular 
response, inducing TH1 differentiation, which become a major source of IFNγ. Not 
surprisingly, IL-12p40 deficient mice are highly susceptible to M. avium infection and the 
neutralization of IL-12 exacerbated M. avium infection. It has also been reported that in the 
absence of IL-12, IFNγ responses were drastically reduced and upon exogenous 
administration of recombinant IL-12, IFNγ responses were enhanced leading to increased 
protection 58, 59. Additionally, TLR-2 and CD40 appear to be required for an optimal IFNγ-
dependent protective immune response to M. avium. Both TLR-2 and CD40 play an 
important role by generating optimal levels of IL-12p40 21, 60. 
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Figure 2 – Classical activation of macrophages. Macrophages can produce numerous cytokines, 
namely TNFα and IL-12, which are essential for macrophage activation. IL-12 has the ability to 
stimulate the production of IFNγ by NK cells and TH1 cells. IFNγ play a major role in the activation of 
macrophages. Activated macrophages will enhance the production of IFNγ, creating a positive 
reinforcement loop. 
 
1.3.6 Other innate and adaptive immune cells 
There are other cells that participate in the innate response besides macrophages, 
such as DCs, NK cells, and neutrophils. 
The role played by NK cells in mycobacterial infections is not clear, however there are 
several studies demonstrating a role for this cell population. It is known that NK cells are able 
to secrete cytokines such as IFNγ, a major modulator of M. avium infection. The role of NK 
cells during M. avium infection was demonstrated through the depletion of NK cells by using 
an anti-NK1.1 monoclonal antibody. The results obtained in this in vivo model showed an 
uncontrolled multiplication of M. avium in C57Bl/6 mice 61. By using in vitro assays, it has 
been demonstrated that NK cells interact with macrophages and this leads to a reduction in 
mycobacterial proliferation 62. 
The involvement of neutrophils in mycobacterial infections has been discussed 
controversially in the literature in the past few years 63, 64. Since neutrophils only ingest 
mycobacteria in the first hours of infection and since the infection will become chronic, it is 
unlikely that neutrophils kill M. avium. However, the neutrophils as a cell type are more 
complex than the simple ingestion and killing 65. The neutrophils play an important role in 
determining the immune response and also in cooperating with other cell types to improve 
the effector responses of the immune system. The importance of neutrophils in the protective 
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response was shown by the depletion of neutrophils using a monoclonal antibody which led 
to the exacerbation of the infection 63, 64. Infected neutrophils might be involved in the 
recruitment of a protective type 1 response through the secretion of chemokines and 
cytokines (such as IL-12 and TNFα) 64. More recently, it has been suggested that neutrophils 
might be involved in the adaptive immune response by crosstalk with DCs in order to 
increase mycobacterial antigen presentation 65, 66. 
DCs are specialized in the presentation of antigen to T cells. Mycobacteria infected 
DCs migrate to the lymph nodes under the influence of IL-12p40, IL-12p70, CCL19 and 
CCL21 to drive naïve T cells differentiation toward a TH1 phenotype. DCs are the major 
source of IL-12, an essential cytokine in the production of IFNγ by immune cells (CD4+ TH1 
cells and NK) 6, 67. The role of DCs in the mycobacterial infection was demonstrated through 
the depletion of DCs. Tian et al, have shown the importance of DCs in the initiation of the 
adaptive T cell response, since the absence of DCs led to a delay of CD4+ T cell response, 
which consequently led to the exacerbation of infection 68. 
Early recognition of M. avium is crucial to bacterial growth control. However, 
protective immunity against M. avium also requires efficient cell mediated immune responses 
by CD4+ and CD8+ T cells. This section will summarize how T cells contribute to protective 
immunity against M. avium. It is clear that CD4+ T cells play a crucial role in the control of 
infection by atypical mycobacteria, such as M. avium, being the major producers of IFNγ. 
The secretion of this cytokine leads to activation of mycobacterium-infected macrophages, 
inducing NO and RNS production but also IL-12 and TNFα, which contribute to the control of 
the pathogen. M. avium is opportunistic pathogen infecting immunocompromised individuals 
such as AIDS patients with low CD4+ T cells counts 6, 11. The fact that a severe depletion of 
the CD4+ T cells in AIDS patients favors the establishment of infection by this mycobacteria, 
suggests that T cells play a major role in the host defense against M. avium infection in 
humans. In vivo experiments, using CD4+ T cell deficient mice confirmed the requirement of 
CD4+ T cell in the M. avium growth control 69. Despite substantial evidences that CD4+ T cells 
are crucial for an effective defense against M. avium, the role of CD8+ T cells remains 
unclear and does not appear to influence the control of M. avium infection. In a CD8+ T cell 
deficient mice the bacterial load did not show any difference compared to C57BL/6 mice 69. 
Another study with a β2-microglobulin deficient mice confirmed the negligible role played by 
the MHC class I-restricted CD8+ T cells 35, 70. 
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1.4 Immunopathology of mycobacteria 
After M. avium recognition and up take by the resident macrophages, the bacteria can 
interfere with key antimicrobial mechanisms and start to replicate intracellularly. Infected 
macrophages will produce a range of cytokines and chemokines that will attract additional 
monocytes, neutrophils and DCs. Infected macrophages or DCs can migrate to the draining 
lymph node under the influence of IL-12p40 and IL-12p70 and serve as APC to drive naïve T 
cell differentiation towards a TH1 phenotype. Protective antigen-specific TH1 cells migrate 
back to the infection site and produce IFNγ, thereby leading to macrophage activation 6, 15. 
After arriving at the site of infection, the immune cells of both innate and adaptive immunity 
form the classical granuloma. Granulomas are well-organized aggregates of immune cells, 
namely heavily infected macrophages and stimulated macrophages which have differentiated 
into multinucleated giant cells, epithelioid cells, foamy (lipid-rich) macrophages and 
neutrophils, surrounded by a ring of lymphocytes, largely CD4+ T cells, but also CD8+ T cells, 
B cells, DCs, NK cells and by fibroblasts, which create a peripheral fibrotic capsule 6, 71, 72. 
The mycobacterial granuloma contributes to host protection through different functions. The 
granuloma’s main function is to constrain and prevent the dissemination of the mycobacteria, 
concentrating the immune response to a limited area. Furthermore, T cell-activated 
macrophages can lead to the control of bacterial growth. Granulomas also restrict tissue 
damage by shielding the surrounding tissue from the chronic inflammation. The mycobacteria 
can persist within the granuloma structure for decades in a latent state. This latent state is 
characterized by the control of bacterial proliferation through the balance of immune 
responses 71, 73. 
For some unknown reasons, mycobacteria can reactivate due to a deregulation of 
immune responses. This will lead to granuloma progression and no control of mycobacterial 
growth. In such situations, the granuloma is no longer able to contain the bacteria and these 
lesions grow to macroscopic sizes and may evolve to show areas of central necrosis. This 
type of lesions is present not only in M. avium infection but also in M. tuberculosis infection. 
In fact, the hallmark of human TB is the caseating granuloma with an amorphous acellular 
core of necrotic material that resembles “cheese” (with caseum being the Latin word for 
cheese). The accumulation of caseum in the center of the granuloma leads to the collapse of 
the granuloma center, releasing the virulent bacilli to other parts of the tissue where more 
lesions will be formed 15, 16, 73. 
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Figure 3 – Sequence of events following the infection with M. avium. The infection starts with the 
phagocytosis of the bacteria by tissue macrophages. Upon the contact with M. avium, DCs can 
migrate to the lymph nodes under the influence of IL-12p40 and IL-12p70 to drive naive T cell 
differentiation toward a TH1 phenotype. TH1 cells migrate back to the infection site to form the classical 
granuloma. 
 
1.4.1 Granuloma necrotizing models 
Some studies using knockout mice infected with M. avium have clearly shown the 
importance of T cells in the development of protective immunity against mycobacterium 
infections. These studies also showed that although the assembly of a granuloma may occur 
Infection 
Granuloma 
Structered Granuloma 
Necrosis Caseation 
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in the absence of T cells, the granuloma is poorly structured. More interesting, neither nude 
nor CD4 deficient mice exhibited central necrosis. Morphologic analysis showed smaller 
lesions and extensive accumulations of infected macrophages and few lymphoid cells. On 
the other hand, the CD8 deficient mice present central necrosis similar to that found in 
C57Bl/6 mice 69, 74. 
The role of IFNγ in granuloma formation was demonstrated by Flórido et al using 
IFNγ deficient mice infected with M. avium 69. The histological analysis showed severe 
deficiencies in the formation of granulomas and the absence of necrosis. No granulomas 
were found in IFNγ deficient mice, but instead some accumulations of macrophages heavily 
infected with M. avium were identified 69, 74. The importance of IFNγ inducers, such IL-12, IL-
6 and CD40 in granuloma formation is also described in the literature. The IL-12 or CD40 
deficient mice also showed lack of cellular infiltration and absence of necrosis as was 
observed using IFNγ deficient mice. On the other hand, IL-6 deficient mice showed well-
structured granulomas, however these consisted of smaller lesions with less evidence of 
necrosis compared to WT mice 23, 69, 74. 
To address the role of TNF in the formation of granulomas, mice with genetic ablation 
in TNF 75, p55 TNF receptor (TNFRp55) 69, 76 or TNF-related apoptosis inducing ligand 
(TRAIL) 77 were used. The action of TNF is mediated by two different receptors, the type I 
and type II TNF receptors, also known as p55 and p75 respectively 78. The TNFRp55 has 
been shown to be important in the control of TB infection in mice 79. On the other hand, 
TRAIL is expressed by different cell types and is capable to bind to death receptors, which 
contain a death domain in the intracellular region to induce cell apoptosis 80, 81. It was shown 
that TNFRp55 is not required for the assembly of the granuloma and even in the absence of 
TNF, TNFRp55 or TRAIL necrosis still appeared 75-77. 
Curiously, the same observation was made in certain inbred strains of mice such as 
BALB/c or DBA/1. In fact, despite similar levels of M. avium proliferation found in these 
strains compared with C57BL/6 mice, the development of granuloma necrosis it was not 
observed. These experiments have shown the role of complement component C5 on the 
development of the granuloma progression, since DBA-1 strain were C5 deficient 82. The lack 
of C5 led to a diminished expression of chemokines and cytokines, which probably affected 
the recruitment of leukocytes 83, 84. These models provided evidence that complement 
component C5 is required not only for the efficient organization of granuloma but also for the 
development of the granuloma necrosis 82. 
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1.5 Mycobacterium avium study model 
The mouse model offers the best tool for the study of development and progress of 
necrotic granulomas. Nevertheless, normal mice infected with M. tuberculosis develop 
granulomas that seldom undergo necrosis. These granulomas are poorly organized and 
exclusively cellular; they lack fibrosis or hypoxia; the bacterial counts remain at a relatively 
high but apparently controlled level throughout the course of the disease; and all the mice 
ultimately die of progressive infection. This does not readily recapitulate the pathology seen 
in the human disease 6, 69, 73. However, although lacking a good model of TB in mice, TB 
lesions can be found in guinea-pigs and rabbits infected with low-doses of virulent M. 
tuberculosis. Unfortunately, this can be very restrictive in the experimental point of view, 
since the availability of these species is small 85. The Appelberg group has developed a 
granuloma necrosis model that mimics the human pathology of M. tuberculosis. Using a low 
dose (102 colony-forming units (CFUs)) inoculum of a highly virulent strain of M. avium 
(ATCC 25291) in C57BL/6 mice, it is possible to observe the development of granuloma 
necrosis in the lungs and liver after approximately four months of infection. This type of 
infection is characterized by the formation of small lesions that grow progressively into large 
granulomas that undergo central necrosis, which bears many resemblances with the lesions 
found in humans infected with M. tuberculosis or M. avium. Curiously, the same mice 
infected with the same strain of M. avium but with a higher dose (106 CFUs) never developed 
this type of lesion 69, 86. 
 
2. Hypoxia and mycobacteria pathology 
In an effort to better understand the mechanisms underlying the development of 
caseous necrosis, some studies have shown different evidences of severe hypoxic regions at 
the center of necrotic granulomas. It was already demonstrated that M. tuberculosis 
granulomas in guinea pigs, rabbits and nonhuman primates became hypoxic 85. In contrast, 
severe hypoxia was not demonstrated in pulmonary lesions of C57BL/6 mice infected with M. 
tuberculosis strain H37Rv. However, when using C57BL/6 mice infected with M. avium strain 
TMC724 hypoxic granulomas were observed87. However, both studies have shown hypoxia 
by two different methods: the direct measurement of the partial pressure of oxygen (pO2) 
using a flexible Clarke type electrode catheter, or by using the pimonidazole marker 
providing immunohistochemical evidence of hypoxia. Pimonidazole hydrochloride is an 
imaging agent that is activated under hypoxic conditions in mammalian tissue 85, 87. Recently, 
through a noninvasive positron emission tomography (PET) imaging of live animals, hypoxic 
lung necrotic granulomas in C3HeB/FeJ mice infected with M. tuberculosis strain H37Rv 
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were demonstrated. In this technique, each mouse was injected via the tail vein with 
Copper(II)-diacetyl-bis(N4-methyl-thiosemicarbazone), which in normoxic cells is reduced 
while in live cells in hypoxia is retained 88. 
 
2.1 Hypoxia-inducible factor 
The maintenance of oxygen homeostasis is an essential process in mammalian cells. 
The understanding of the molecular mechanism underlying this fundamental aspect of cell 
biology has started only few years ago 89, 90. When the balance between oxygen supply and 
demand is affected, tissue hypoxia and cell death can rapidly occur. Hypoxia is induced not 
only as a global consequence of a decreased oxygen tension, but also locally at sites of 
inflammation, tissue ischemia and injury, and solid tumor growth 91, 92. Therefore, adaptation 
to hypoxia is a vital survival mechanism in mammalian cells. These cells have the ability to 
adapt to conditions of hypoxia through the induction of the expression of several genes. The 
hypoxia-inducible factor-1 alpha (HIF-1α) has emerged as a master regulator, mediating a 
wide range of physiological and cellular mechanisms indispensable to adapt to hypoxia. HIF-
1α is directly involved in angiogenesis 93, erythropoiesis 94, cell growth and differentiation 95, 
survival and apoptosis 96. 
Under normoxic conditions, HIF-1α has a very short half-life. At normal 
concentrations of O2, HIF-1α is suppressed by hydroxylation of two prolyl residues (Pro-402 
and Pro-564). This modification allows the interaction with the von Hippel-Lindau tumor 
suppressor protein (pVHL). pVHL is the recognition component of E3 ubiquitin ligase 
complex that targets HIF-1α for ubiquitination and proteasomal degradation. Under hypoxic 
conditions, prolyl hydroxylation is suppressed and HIF-1α escapes from proteasomal 
degradation. Thus, HIF-1α becomes stabilized and translocates from the cytoplasm to the 
nucleus, where it dimerizes with HIF-1β. The HIF complex formed becomes transcriptionally 
active, binding hypoxia-response elements (HREs) 91, 97. Classical HIF-1α target genes 
include the vascular endothelial growth factor (VEGF) 98, erythropoietin 94, glucose 
transporters 99 and transferrin 100. 
Besides HIF-1α, HIF-2α is also involved in the regulation of physiological and cellular 
mechanisms in the hypoxia adaptation101. The HIF-2α and HIF-1α subunits are structurally 
and functionally similar, since they also have the two prolyl residues, which are hydroxylated 
in normoxia, and are targeted for degradation by VHL ubiquitin E3 ligase complex. In hypoxic 
conditions, the inhibition of hydroxylation results in stabilization of HIF-2α which 
consequently translocates to the nucleus, where it dimerizes with HIF-1β, resulting in the 
HIF-2 complex, which transactivates HRE-target genes 102,103. A number of studies also 
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showed that HIF-2α plays an important role in regulating macrophage responses to hypoxia, 
however there is some debate about which form of HIF is the most important in the 
regulation of macrophages in hypoxic conditions 104, 105. 
 
 
 
Figure 4 – HIF-1α pathway. Under normoxia the HIF-1α is rapidly degraded. In this condition, HIF-1α 
is suppressed by hydroxylation and target for proteasomal degradation. During hypoxia, HIF-1α 
becomes stabilized and is translocated to the nucleus, where the HIF complex becomes 
transcriptionally active. 
 
2.2 Immune system and hypoxia 
Microenvironmental conditions are frequently encountered in injured tissues and are 
characterized by low levels of oxygen. This is probably due to a combination of some factors 
including the excessive oxygen consumption by highly metabolically activated resident cells, 
but also by infiltrating immune cells. It has also been shown that chronic inflammation leads 
to a marked deregulation of vasculature 106, 107. Thus, the immune cells that are recruited to 
these inflammation sites need to adapt to hypoxia in order to remain functionally active. 
Lewis and colleagues showed that hypoxic conditions profoundly affect a broad range of 
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myeloid cell properties in vitro, e.g., phagocytosis, cell surface marker expression, secretion 
of cytokines, chemokine receptor levels, adhesion, migration and cell survival108. To maintain 
their biological activities in hypoxia, immune cells need to shift their metabolism to anaerobic 
glycolysis to generate ATP. Some studies in hypoxia environment have shown that inhibition 
of glycolysis can directly inhibit ATP production and subsequently, myeloid cell properties as 
diverse as adhesion, extravasation, motility and invasion. Recently, HIF-1α has arisen as a 
key regulator of glycolysis and immune functions 106, 109. 
 
2.3 HIF-1α function in immune cells 
The crucial role of HIF-1α in immune cell functions using different conditional 
knockout mice lacking HIF-1α has been demonstrated in several studies. The influence of 
HIF-1α in the innate immune system is relatively well established and a role in the adaptive 
immune system has recently been proposed 90, 109. 
The absence of HIF-1α in cells from the myeloid lineage showed a profound 
impairment of myeloid cell aggregation, motility, invasiveness, and bacterial killing 109. In fact, 
Anand and colleagues have shown by in vitro assays, that HIF-1α activation led to an 
increase of the phagocytic activity and to bacterial killing under hypoxic conditions, when 
compared to normoxic conditions 110. HIF-1α is strongly stimulated under bacterial exposure 
and has the ability to regulate the production of key immune effectors molecules, including 
NO and TNFα 111. Nevertheless, studies using conditional knockout mice lacking HIF-1α in T 
cells 112, B cells 113, neutrophils 114 or DCs 115, have demonstrated an important influence of 
HIF-1α in the immune function. The loss of HIF-1α in DCs led to an impairment of DCs 
migration from the periphery, tissue and blood circulation and consequently, to a decrease of 
DCs ability to stimulate T cells. In addition, the upregulation of HIF-1α during hypoxic 
conditions led to enhanced apoptosis of immature DCs 90, 115, 116. In the adaptive immune 
response, HIF-1α works as a key metabolic sensor, regulating the differentiation of TH17 and 
regulatory T cell (Treg) 
117, 118. The absence of HIF-1α in T cells has shown the induction of 
higher levels of pro-inflammatory cytokines in response to T cell receptor activation 112. 
Surprisingly, it was found that under normoxia conditions HIF-1α complex was also 
upregulated. Apparently non-hypoxic stimuli as glucose 119, lipopolysaccharide (LPS) 120, 
TNFα 121 IFNγ 122 and nuclear factor- kappa B (NF-κB) 123 are possible modulators of HIF-1α 
transcription and therefore able to influence the expression of hypoxic genes. 
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3. Aims 
 The development of necrosis is a crucial mechanism in the progression of M. avium 
infection, however still poorly understood. Therefore, the better understanding of necrotizing 
mechanism and how granulomas can control the M. avium infection is needed. Thus, the 
main goal of this thesis is to understand the mechanism underlying caseous necrosis. Since, 
recently, some literature has described the presence of hypoxia at the center of necrotic 
granulomas and since necrosis only occurs when granulomas increase in size, we suggest 
that necrosis is a direct consequence of the absence of oxygen. Here, we show that 
granuloma increase in size and became less vascularized before the development of 
necrosis. We evaluate the impact of lacking HIF-1α in myeloid cells and the quantification of 
HIF-1α during in vivo M. avium infection. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
METHODS 
 
  
   
 21 
Mice 
C57BL/6 wild-type (WT) mice were bred in our facilities from a breeding pair 
purchased from the Harlan Iberica (Barcelona, Spain). HIF-1α deficient C57BL/6 mice (HIF-
1α-/-) were obtained in our facilities after back-crossing the B6.129-Hif1αtm3RSjo/J and the 
B6.129P2-Lyz2tm1(cre)Ifo/J (LysMcre mice) strains, both from the Jackson Laboratory (Bar 
Harbor, ME, USA), based on the Cre-lox system. Briefly, the B6.129-Hif1αtm3RSjo/J strain has 
loxP sites on either side of exon 2 of the HIF-1α gene and LysMcre mice have a Cre 
recombinase inserted into the first coding ATG of the lysozyme 2 gene (Lyz2). The crossing 
of these two strains of mice resulted in the deletion of the HIF-1α gene only in myeloid cells 
including monocytes, mature macrophages and granulocytes. The first generation obtained 
was HIF-1α heterozygous; the second generation obtained was HIF-1α heterozygous (single 
knockout) and homozygous (double knockout). After confirming the genotype of each animal, 
the double knockouts were successively crossed to obtain an offspring of HIF-1α double 
knockouts (third generation). The genotyping was performed according to the genotyping 
protocols database from Jackson Laboratory (Bar Harbor, ME, USA).  
All mice were kept in our animal facilities in high-efficiency particular air (HEPA)-filter-
bearing cages under 12 hours light cycles, and fed autoclaved chow and water ad libitum. All 
mice were used at 8-12 weeks of age. All experiments were performed in accordance with 
the National and European guidelines and approved with by the IBMC.INEB Animal Ethics 
Committee. 
 
Bacteria 
The highly virulent M. avium strain (ATCC 25291 SmT) was obtained from the 
American Type Culture Collection (ATCC) (Manassas, VA). Mycobacteria inoculum was 
obtained from a smooth-transparent morphotype colony, grown in Middlebrook 7H9 medium 
(Difco, Detroid, MI) containing 0.04% Tween-80 (Sigma, St Louis, MO) and supplemented 
with 10% albumin-dextrose-catalase (ADC) at 37ºC until the mid-log phase of growth. 
Bacteria were harvested by centrifugation and resuspended in a small volume of saline 
containing 0.04% Tween 80. The bacterial suspension was sonicated with a Branson sonifier 
(Danbury, CT) in order to disrupt bacterial clumps and stored in aliquots at -80ºC until 
bacterial load determination and use in in vivo infection. Before inoculation, bacterial aliquots 
were thawed at 37ºC and diluted in saline to the desired concentration (5x102 CFU/ml). 
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In vivo infection 
C57BL/6 and HIF-1α-/- mice were infected with 102 CFUs of M. avium strain 25291 
through a lateral tail vein. Infected mice were euthanized (isofluorane plus cervical 
dislocation) at different times points after infection and the livers, spleens and lungs were 
aseptically collected. A portion of the liver was fixed in 4% paraformaldehyde for histological 
analysis. Spleen and liver samples were collected in Dulbecco’s modified Eagle’s tissue 
culture medium (DMEM; Life Technologies, Paisley, UK) containing 10% fetal bovine serum 
(FBS; Life Technologies), 5% glutamine and 1% penicillin/streptomycin (P/S).The bacterial 
load was determined in tissue homogenates from infected mice, by serial dilutions in distilled 
sterile water with 0.05% Tween and plated, in duplicate, onto Middlebrook 7H10 agar 
medium (Difco, Detroid, MI) supplemented with oleic acid-albumin-dextrose-catalase 
(OADC). 7H10 plates were incubated for 10 days at 37 °C and the numbers of CFU were 
counted using a magnifying glass. The bacterial load was calculated taking into account the 
dilution factor and the final volume of the tissue homogenate. 
 
Isolation of liver mononuclear cells 
Liver mononuclear cells were isolated from the liver homogenate by density 
centrifugation. A single cell suspension was obtained from the liver by passing the organ 
through a 70 µm cell strainer (BD Biosciences, San Jose, CA). Liver cells were washed at 
least two times (500g, 10 minutes) with phosphate-buffered saline (PBS) until the 
supernatant got clear. After the last centrifugation, cells were resuspended in DMEM and 
gently layered in a falcon with density gradient reagent - Histopaque 1083 (Sigma-Aldrich, 
Taufkirchen, Germany). After centrifugation at 1000g for 25 minutes at room temperature 
(RT) without acceleration or brake, liver mononuclear cells were recovered from the 
interphase between the histopaque and the DMEM. Cells were washed with DMEM to 
remove histopaque residues and liver mononuclear cells were finally resuspended in DMEM. 
 
HIF-1α quantification 
Liver mononuclear cells were fractionated into cytoplasmic and nuclear protein 
extracts using a cell fractionation kit according to the manufacturer's instructions (BioVision, 
Mountain View, CA). Total HIF-1α was quantified using the cytoplasmic extracts by a two-site 
sandwich enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s 
instructions (R&D Systems, Minneapolis, MN). Positive controls were provided by the 
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manufacturer. All samples were assayed in duplicated. The values were normalized to the 
total liver mononuclear cell number isolated from each mouse. 
 
IFNγ quantification 
Spleen cell suspensions from infected and control mice were individually prepared 
using Potter-Elvehjem tissue homogenizer, resuspended in DMEM, supplemented with 10% 
fetal calf serum (FCS; Life Technologies). Erythrocytes were lysed by incubation of the cell 
suspensions with a hemolytic buffer (155 mM NH4Cl, 10 mM KHCO3, pH 7.2) for 5 minutes at 
RT. The cell suspensions were then thoroughly washed with Hanks’ balanced salt solution 
(Life Technologies) and resuspended in DMEM with 10% FCS, 5% glutamine and 1% P/S. 
Cells were cultivated at a density of 2x105 cells/well in a U-bottom, 96-well microtitre plate. 
Cells were incubated in triplicate in DMEM with 10% FCS with no further stimulus or 
stimulated with mycobacterial antigens (4 µg/ml) or concanavilinA (4µg/ml, 
Sigma).Supernatants from the cultures were collected after 72 hours of culture at 37ºC in a 
7% CO2 incubator and the IFNγ produced was quantified by the ELISA method using anti-
IFNγ-specific affinity-purified monoclonal antibodies (R4-6A2 as capture and biotinylated AN-
18 as detecting antibody). Finally, a standard curve was generated with known amounts of 
recombinant murine IFNγ (Genzyme, Cambridge, CA). 
 
Flow cytometry 
For the immunofluorescence staining, 106 cells were incubated in a 96-well plate with 
different combinations of the following monoclonal antibodies. Briefly, a mixture of fluorescein 
isothiocyanate (FITC) – conjugated anti-CD19 antibody (dilution 1:50), phycoerythrin (PE) – 
conjugated anti-CD3 antibody (dilution 1:80), V450 – conjugated anti-CD4 antibody (dilution 
1:200) and V500 – conjugated anti-CD8 antibody (dilution 1:150) was used in order to 
identify the different lymphocyte populations; and a mixture of brilliant violet 510 (BV 510) – 
conjugated anti-CD11b antibody (dilution 1:100), brilliant violet 421 (BV 421) – conjugated 
anti-CD11c antibody (dilution 1:100), allophycocyanin (APC) – conjugated anti-Ly6G 
antibody (dilution 1:200), allophycocyanin with cyanin-7 (APC/Cy7) – conjugated anti-F4/80 
antibody (dilution 1:80) and FITC - conjugated anti-DX5 antibody (dilution 1:200) to identify 
the myeloid cells as well as the NK cells. The monoclonal antibodies were diluted in PBS 
containing 3% FBS and 0.01% sodium azide (NaN3). After 30 minutes of incubation at 4ºC in 
the dark, cells were washed twice in PBS/3%SBF/0.01%NaN3, and fixed with 
paraformaldehyde 4% for 20 minutes at RT. Cells were washed once more in 
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PBS/3%SBF/0.01%NaN3 and resuspended in PBS/3%SBF/0.01%NaN3. All the antibodies 
were obtained from Biolegend except for V450-CD4 and V500-CD8 that were obtained from 
BD Bioscience. Single-stainings and unstained samples were used to calibrate the voltages 
for sample acquisition and for colour compensation on the flow cytometer. The acquisition of 
the spleen and liver mononuclear cells was performed using a FACS Canto II flow cytometer 
using BD FACSDiva software (BD Biosciences). Data were analyzed using FlowJo software 
(Tree Star, Ashland, OR). To determine the cell number of each cell population, the number 
of gated events was multiplied by the total cell number (counted using Kova chambers) and 
divided by the total number of events select by forward scatter (FSC) / side scatter (SSC) 
parameters. 
 
Gating strategy 
Cells were selected on the basis of FSC/SSC and the singlets were gated according 
to size versus the width. For the lymphocytes analysis we used CD19 as a marker of B cells 
and CD3 to label T cells. Inside this gate CD4+ T and CD8+ T cells were distinguished (Fig. 
5A). For the myeloid analysis the first gate was made on Ly6Ghigh/CD11b+ defined to be 
neutrophils. Another gate was made on CD11b+/Ly6G- in order to identify other types of 
myeloid cells. CD11b+ is expressed on monocytes, macrophages, neutrophils, DCs and NK. 
On the CD11b+ gate we plotted the F4/80 against DX5 to distinguish the macrophages by the 
expression of CD11b+/Ly6G-/F4/80+/DX5- and NK by the expression of CD11b+/Ly6G-/F4/80-
/DX5+. Still on the CD11b+ gate we identify DCs by the expression of CD11b+/Ly6G-
/CD11chigh/DX5- (Fig. 5B). 
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Figure 5 – Gating strategy – Spleen and liver cells were stained with different markers in order to 
identify different lymphocyte (A) and myeloid populations (B). 
Histology 
Portions of the organs from infected mice were fixed in buffered formaldehyde and 
embedded in paraffin. Sections were stained with haematoxylin and eosin, using a standard 
histological technique. For the detection of acid-fast bacteria, sections were stained by the 
Ziehl-Neelsen method. 
 
Morphometric analysis of the granulomatous area 
Histological sections of liver stained with haematoxylin and eosin (HE), from infected 
animals were captured using an Olympus CX31 light microscope equipped with a DP-25 
camera (Imaging Software CellˆB, Olympus, Center Valley, PA). Random fields within each 
section under study were analyzed. The determination of granulomatous/cell infiltration area 
was done in a total tissue area ranged from 6 to 9 x106 µm2, corresponding to a number of 
fields analyzed in each section between 5 and 6. The number of cellular infiltrates was the 
sum of all granulomatous/cell infiltration areas. It was analyzed one liver section per animal 
and measurements were done blind. To determine the liver area covered by granulomas, the 
A 
B 
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NIH ImageJ software program was used. The percentage of granuloma area was calculated 
for each mouse by dividing the sum of granulomatous areas by the total area of the liver  
section analyzed. 
 
Immunohistochemistry 
Sections were deparaffinized in xylene, and hydrated in an ethanol gradient (100%, 
96% and 75%). The sections were next permeabilized in PBS containing 0.1% Triton X-100 
and 0.1% Tween 20 (wash solution) for 5 minutes. Antigens were retrieved with 10mM 
sodium citrate buffer for 30 minutes at 96ºC. Endogenous peroxidase activity was blocked 
with 0.3% hydrogen peroxidase in methanol for 35 minutes at RT, followed by blocking the 
nonspecific antibody binding with normal horse serum (Vector Labs, Burlingame, CA; Dilution 
1:50) in wash solution containing 5% BSA for 1 hour in a humid chamber at RT. Sections 
were incubated overnight at 4ºC with the following primary antibodies in wash solution: rat 
IgG monoclonal anti-mouse F4/80 (Clone Cl:A3-1; Abcam; Dilution 1:50) or rat IgG 
monoclonal anti-mouse Endomucin (Clone V.7C/.1; Abcam; Dilution 1:50). The day after, 
sections were washed in PBS and incubated with goat anti-rat IgG, horseradish peroxidase 
conjugated antibody (GE Healthcare; Dilution 1:100) in wash solution for 1 hour in a humid 
chamber at RT. Development was performed with DAB (3,3-diaminobenzidine) labeling 
system (Vector Laboratories, Burlingame, CA). Sections were then counterstained with Gill’s 
hematoxylin for 2 minutes, dehydrated using graded alcohols (75%, 96% and 100%) and 
xylene, and mounted with DPX (Sigma). Negative controls were generated on adjacent 
sections by omitting the primary antibodies. 
 
Statistics 
The results are presented as mean ± SD, and the statistical differences between 2 
groups were determined by the unpaired Student t-test or for multiple group comparisons, 
the one-way ANOVA test with a Tukey’s posttest was performed using GraphPad Prism 
software (San Diego, CA, USA). Statistically significant is labeled * for P<0.05, ** for P <0.01 
and *** for P <0.001 or + for P<0.05, ++ for P <0.01 and +++ for P <0.001. 
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Necrosis occurs in macroscopic visible granulomas in C57BL/6 
mice 
As referred previously, the Appelberg group has developed a study model using 
C57BL/6 mice infected with a low dose inoculum of a virulent strain of M. avium (ATCC 
25291) 69, 82. This study model allowed the establishment of a progressive infection 
characterized by the formation of small granulomas which gradually increased in size to 
macroscopic lesions and evolved to central necrosis at four months post-infection as it is 
shown in figure 6. Liver macroscopic analysis from infected C57BL/6 mice revealed lesion 
sizes between 1 and 3 mm in diameter (Fig. 6D). The hypothesis formulated in this work was 
that granuloma necrosis could take place when the inflammatory lesions reached larger 
sizes, generating a hypoxic environment leading to necrosis. 
 
 
Figure 6 - Granuloma progression in the livers from C57BL/6 mice infected with M. avium 
25291. Representative lesions in HE stained liver sections from animals intravenously infected with 
100 CFUs of M. avium 25291, at days 30 (A), 60 (B), 90 (C) and 120 (D) post-infection. 
 
Granuloma vascularization during granuloma progression in 
C57BL/6 mice 
The role of nutrient deprivation and hypoxia in the granuloma necrosis has been 
described. In fact, granulomas are poorly vascularized structures which lead to a diminished 
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blood supply and consequently to a reduction of nutrient and oxygen at the central core 87. 
To evaluate vascularization during granuloma development we evaluated the expression of 
endomucin, a known endothelial cell marker 124, by immunohistochemistry (IHC). A positive 
staining was observed on the capillaries surrounding small granulomas, inside the 
intermediate size granuloma and in areas immediately surrounding the necrotic core of 
bigger granulomas (Fig. 7 A-C). No staining was observed in necrotic areas of intermediate 
size granuloma (Fig. 7D) or in the center of necrotic granuloma since it consisted of 
amorphous acellular content. 
 
 
Figure 7 - Endomucin expression evaluation in the livers from C57BL/6 mice infected with M. 
avium 25291. Paraffin sections of livers were analyzed by IHC using mAb endomucin (A – D). 
Endomucin expression was evaluated at days 90 (A) and 120 (B – D) post-infection. 
 
Granulomata is mainly constituted by macrophages 
Some studies have been focused on the role of macrophages under hypoxic 
conditions. It has been described that under hypoxic conditions myeloid cell properties such 
as transmigration, motility and invasion could be affected 109. In this work, we evaluated the 
granuloma constitution on macrophages using F4/80, a known cell marker for resident 
(Kupffer cells) and recruited macrophages 125. The F4/80 expression was evaluated by IHC, 
using liver histological sections from infected C57BL/6 mice (Fig. 8 A-D). The results showed 
a positive staining in the granulomas from day 30 until 120 post-infection, indicating that 
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macrophages are present in small granulomas as well as in bigger granuloma, which were 
shown to be poorly vascularized. 
 
 
Figure 8 – F4/80 expression evaluation in the livers from C57BL/6 mice infected with M. avium 
25291. Paraffin sections of livers were analyzed by IHC using mAb F4/80 (A - D). F4/80 expression 
was evaluated at days 30 (A), 60 (B), 90 (C) and 120 (D) post-infection. 
 
HIF-1α is increased during M. avium infection 
Previous studies have shown the presence of hypoxic regions at the center of 
necrotic granulomas induced by M. tuberculosis or M. avium infection 85-87. Furthermore, 
since our observations revealed that small non-necrotic granulomas were poorly 
vascularized structures, and as the granulomas enlarged, the central core became less 
vascularized, probably leading to a decrease in oxygen supply, constituting an hypoxic 
environment, we hypothesized that hypoxia could be the major cause for granuloma necrosis 
in our study model. Therefore and considering HIF-1α to be the master regulator of hypoxia 
91, 97, we evaluated HIF-1α protein content in liver mononuclear cells during M. avium 
infection. A significant increase of total HIF-1α protein levels in the liver mononuclear cells 
from infected animals was found compared with the non-infected animals, starting at day 60 
post-infection (Fig. 9). These results indicate a HIF-1α accumulation, before the onset of 
granuloma necrosis (60 days and 90 days post-infection). 
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Figure 9 - Analysis of total HIF-1α protein in liver mononuclear cells during M. avium infection. 
C57BL/6 mice were intravenously infected with 100 CFUs of M. avium 25291. Total HIF-1α protein 
was determined at days 0, 30, 60, 90 and 120 post-infection by ELISA as described in the material 
and methods section. Groups of non-infected mice (day 0) were included at every time-point of 
infection studied. Each group of non-infected mice comprised three to four animals and each group of 
infected mice comprised four to six animals. Data are expressed as means ± S.D. of protein levels 
calculated to the total liver mononuclear cells for individual mice. **P0.01, *** P0.001 using unpaired 
student t-test, comparing values from infected and non-infected animals. 
 
HIF-1α absence leads to higher bacterial load 
In order to determine the relevance of HIF-1α in in vivo on the proliferation of M. 
avium, WT and HIF-1α-/- mice were infected with 100 CFUs of M. avium 25291, and the 
bacterial loads were quantified in the liver and spleen at different time-points of infection. As 
shown in figure 10, the infection of both strains of mice resulted in a progressive infection 
with no evidence of bacterial control as previously described 69. The growth patterns of 
bacteria in the spleen and liver from infected mice were in agreement with previous 
observations 69. HIF-1α-/- mice showed increased bacterial loads within the spleen starting at 
day 15 post-infection compared to WT mice (Fig. 10B). Concerning the liver, an increased 
bacterial load was found in HIF-1α-/- mice compared to WT mice only at days 15 and 104 
(Fig. 10A). The results indicate that presence of HIF-1α is important in the control of M. 
avium infection as suggested in other infection models 111, 126. Therefore, it might be 
hypothesized that the exacerbation of infection occurs probably due to the lack of hypoxia 
adaptation mechanisms. 
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Figure 10 – HIF-1α presence is important in the control of M. avium infection. Growth of M. 
avium 25291 in liver and spleen from WT and HIF-1α
-/- 
mice intravenously infected with 100 CFUs. 
Bacterial load was determined at different time points (15, 30, 60 and 78 days post-infection). Each 
time-point represents the mean of the log10 CFUs per organ ± SD from at least five mice per group.* 
P0.05, **P0.01, *** P0.001 using unpaired student t-test. 
 
HIF-1α deficient mice develop necrotic granulomas earlier 
compared with C57BL/6 mice 
In order to understand the involvement of HIF-1α during M. avium infection, we used 
a mouse model with a genetic ablation of the HIF-1α transcription factor in the myeloid 
lineage (monocytes, mature macrophages, and granulocytes). In a first attempt to determine 
the influence of HIF-1α deficiency, we analyzed the granuloma progression during infection 
in HIF-1α-/- and WT mice by histological analysis. HIF-1α-/- and WT mice were intravenously 
infected with 100 CFUs of M. avium 25291 and were euthanized at different time-points post-
infection. Previous observations indicated that in WT mice, the granuloma central necrosis 
started around four months post-infection (Fig. 6D). In the beginning of the infection lesions 
in both HIF-1α-/- and WT mice were very small and incipient (Fig. 11A, 11D). By day 60 post-
infection, well-structured granulomas were found with an extensive lymphoid cuff surrounding 
the macrophage core in WT mice (Fig. 11B) as previously reported 69. By day 104 post-
infection, many of those granulomas were found with additional extensive lesions consisting 
of peripheral accumulations of lymphoid cells, fibrosis and vascularization (Fig. 11C). As 
show in Figure 11 (A – F), after day 60 post-infection, differences were evident between the 
lesions in both strains of mice. In fact, in the absence of HIF-1α the onset of necrosis was 
faster compared with WT mice. After day 78 post-infection (data not shown), macroscopically 
visible tubercles were present in HIF-1α-/- mice. Central necrosis was observed in all the HIF-
1α-/- mice analyzed at days 78 and 104 post-infection. Microscopically, these lesions 
A B 
34 
exhibited a well-defined necrotic core with infected macrophages, surrounded by a fibrotic 
capsule and accumulations of lymphoid cells as described previously (Fig. 11 F-I). In 
contrast, caseation was not observed in any of the WT animals analyzed at days 78 and 104 
post-infection. Morphometric analysis determining the infiltrated necrotic or non-necrotic 
area, confirmed the role of HIF-1α on the granuloma progression. Thus, a statistically 
significant increase of necrotic and non-necrotic areas was found in HIF-1α-/- compared with 
WT mice at day 104 post-infection (Fig. 11G). No differences were found at day 30 post-
infection. At day 60 post-infection, despite the slight increase of the non-necrotic area in HIF-
1α-/- compared with WT mice, no statistically significant difference was observed. Similarly, a 
high number of cellular infiltrates were observed in HIF-1α-/- compared with WT mice at day 
104 post-infection (Fig. 11H). No statistically significant differences were observed in the 
number of cellular infiltrates (Fig. 11H) at day 30 or 60 post-infection. These results indicate 
that absence of HIF-1α in myeloid cells anticipates the granuloma necrosis and increases the 
inflammatory cell infiltration during M. avium infection. 
 
 
Figure 11 – HIF-1α absence influences granuloma progression during M. avium infection. 
Representative lesions in HE (A-F) or Ziehl-Neelson (I) stained liver sections from WT (A-C) and HIF-
1α
-/- 
(D-F and I) intravenously infected with 100 CFUs of M. avium 25291 at days 30 (A, D), 60 (B, E), 
and 104 (C, F, I) post-infection. (I) provides a higher power view to show an intermediate layer of 
heavily infected macrophages and an inner core with necrotic material. The percentage of infiltrating 
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area (G) and the number of cellular infiltrates (H) were determined as described in the material and 
methods section. Data are expressed as mean ± S.D of the areas from mice analyzed individually in 
each group. *** P0.001 using unpaired student t-test to compare infected and non-infected. 
+
P0.05 
using unpaired student t-test to compare the area of necrotic versus non-necrotic. 
 
HIF-1α absence induces splenomegaly and hepatomegaly during M. 
avium infection 
Representative photographs of spleens and livers from infected WT or HIF-1α-/- mice 
at day 96 post-infection are shown in figure 12. Infected HIF-1α-/- exhibited a extensive 
splenomegaly and hepatomegaly, when compared with the infected WT. Macroscopic 
observation of the spleens and livers from non-infected WT or HIF-1α-/- animals indicated no 
differences (data not shown). A slight splenomegaly and hepatomegaly was evident between 
the infected WT and the non-infected WT (data not shown). Furthermore, the observation of 
livers from infected WT and HIF-1α-/- animals, showed the presence of necrotic granulomas 
at day 96 post-infection. These observations indicate that HIF-1α influenced the size and 
probably the cellularity of the spleen and livers from mice infected with M. avium 25291. 
 
  
 
 
 
 
 
Figure 12 – HiF-1α absence induces an increase of spleen and liver sizes during infection with 
M. avium 25291. Photographs of livers from WT and HIF-1α
-/-
 mice infected with 100 CFU M. avium 
25291 at day 96 post-infection. Representative images of spleens (A) and livers (B) from WT (I and III) 
and HIF-1α
-/-
 (II and IV) mice. 
 
Infected HIF-1α deficient mice present increased cellularity 
Macroscopic observation of the livers and spleens from M. avium infected HIF-1α-/-
mice indicated an increase in the size and suggested a probable increase in the cellularity in 
these organs. It was previously shown that normal numbers of T cells and macrophages 
persisted after day 60 post-infection when using WT mice infected with a low dose of M. 
avium 25291 69. In order to determine the requirement of a given cell population in the earlier 
development of necrosis in HIF-1α-/- mice, we decided to analyze the spleen and liver 
mononuclear cells by flow cytometry from control or infected WT and HIF-1α-/- mice (Fig. 13).  
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Figure 13 – M. avium infected HIF-1α deficient mice present increased cellularity. Cellular 
composition of the spleens (A) and livers (B) from WT and HIF-1α
-/- 
mice infected with 100 CFU of M. 
avium 25291 at different time points post-infection. Each group comprised at least 5 animals. All data 
are expressed as means + SD. *P0.05, **P0.01, *** P0.001 using unpaired student t-test, 
comparing infected groups within the same time point. 
+
P0.05, 
++
P0.01, 
+++
P0.001 using unpaired 
student t-test, comparing infected versus non-infected animals. 
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The analysis of the spleen showed a significant increase in the number of DCs and 
neutrophils at day 104 post-infection in both infected WT and HIF-1α-/- mice, compared to 
non-infected WT and HIF-1α-/-, respectively. In accordance with the evident splenomegaly 
observed in infected HIF-1α-/- mice, a significant increase in the numbers of macrophages, 
DCs and neutrophils was found compared with infected WT mice. In addition, the analysis of 
the liver mononuclear cells revealed a significant increase in the number of macrophages 
and DCs from infected HIF-1α-/- mice, compared to infected WT mice. The analysis of the 
spleen lymphocyte population did not shown any differences between the infected and non-
infected groups in the beginning of infection, as previously was shown 69. At day 104 post-
infection, a significant increase in all spleen lymphocyte population was noticed, which is in 
agreement with the evident splenomegaly observed in infected HIF-1α-/- mice. In contrast, no 
differences were observed in the analysis of liver lymphocyte populations, with the exception 
of CD19+ cells. Curiously a significant increase of CD19+ cells in the liver was observed in 
infected WT compared to HIF-1α-/- mice, suggesting a higher recruitment of B cells in the 
presence of HIF-1α presence. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION
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In the past few years many cellular and molecular mechanisms underlying the 
structuring of granuloma have been described. However, the mechanism that leads to 
necrosis still poorly understood. Previous work has shown that this process is highly 
dependent on CD4+ T cells, IFNγ and IL-12, and partly on IL-6 and CD40 69, 127. In fact, M. 
avium intravenously infected mice lacking CD4 T cells, IFN-γ, IL-12, IL-6 and the co-
stimulatory molecule CD40 failed to develop granuloma necrosis 69. Additionally, the infection 
of DBA/1 strain 82 also failed to induce macroscopic lesions and did not develop to necrosis 
69. In contrast, it was possible to find macroscopic lesions undergoing necrosis in C57BL/6 
mice lacking TNF-α 75, NO or CD8+ T cells 69. Thus, in the beginning of this work, we 
hypothesized that the granuloma size could be a crucial factor in the development of 
necrosis during M. avium infection. As suggested by Orme, necrosis did not occur when the 
T cells reached the center of the granulomas. In contrast, local necrosis occurred either in 
fibrotic granulomatous lesions or when T cells remained at the peripheral mantle not invading 
the center of the lesion 128. The data obtained in our work suggest that the absence of 
lymphocytes at the center of granuloma is a possible consequence of the reduced 
vascularization in the center of the granuloma. Recently, it has been described that necrotic 
granulomas developed in M. tuberculosis-infected guinea pigs, rabbits and nonhuman 
primates 85, and also in M. avium strain TMC724-infected C57BL/6 mice were hypoxic 87. In 
our study, we used C57BL/6 mice infected with M. avium 25291 to address the granuloma 
vascularization during granuloma progression. The absence of vascularization in small 
granulomas, and the vascularization of large granulomas without necrosis, probably occurred 
due to a homeostatic process of angiogenesis in an attempt to prevent a hypoxic 
environment in the granuloma. Curiously, no vascularization was observed in the center of 
bigger lesions, just before they become necrotic. Our observations are in agreement with 
other studies, also in the context of M. avium infection, where a decreased vascularization in 
the central areas of the granuloma was demonstrated 129. Having in mind these results, we 
can argue that the center of larger granulomas becomes less vascularized, resulting in a 
hypoxic environment that will lead to necrosis in the center of granuloma. To better define a 
possible role of hypoxia in the development of necrotic granulomas in our study model, we 
decided to assess the influence of HIF-1α. In the last 20 years, HIF-1α has been described 
as the master regulator of physiological and cellular mechanisms indispensable in the 
adaptation to hypoxia 97, 106, 109. Under hypoxic conditions, the levels of HIF-1α increase by 
accumulation 97, 109. In our study model, we found an increase in the total HIF-1α protein in 
liver mononuclear cells during infection. Curiously, the peak of HIF-1α production occurred 
60 days after infection, which corroborates the observation of a reduced vascularization of 
the granulomas before the beginning of necrosis development. Based on this, it is possible to 
postulate that granulomas became hypoxic before the onset of granuloma necrosis. 
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However, another alternative explanation may justify the increase of HIF-1α in early time 
points of M. avium infection. Recently, it has been proposed that other factors, rather than 
only hypoxia, are able to modulate HIF-1α expression and degradation. In fact, even under 
normoxia, HIF-1α is induced by bacterial infection and regulated by TNFα and IFNγ 93, 111, 121, 
122. Tissue macrophages are believed to play an important role in the resistance against 
mycobacteria infection being its recruitment and activation crucial in the control of bacteria 
proliferation 6, 7 . It has been described that 95% of the activated macrophages present in 
inflammation infiltrates are derived from exudate monocytes 108, and that they need to move 
against oxygen gradients in order to migrate toward the areas of inflammation 106, 130. Our 
results show macrophage accumulation within the infection site even in late time-points of 
infection, where hypoxic conditions may occur. This is in accordance with other studies, 
indicating that infiltrating macrophages are able to adapt to low oxygen conditions 106, 130. 
Cramer et al has described using in vitro assays and Group B Streptococcus infection of 
macrophages, a significant impairment of motility and invasion of HIF-1α deficient 
macrophages, with a 7-fold increase of bacterial load in the absence of HIF-1α 109. In our 
study, the qualitatively analysis of F4/80 expression in the liver sections from infected WT 
and HIF-1α deficient mice did not indicate any differences in the accumulation of 
macrophages (data not shown). It was found that at early stages of infection, HIF-1α 
deficient mice failed to restrict the spread of the bacteria. This clearly shows that bacterial 
killing is limited in the absence of HIF-1α. The exacerbation of infection in HIF-1α deficient 
mice probably occurred due to the (i) failure in controlling bacterial growth caused by the 
absence of hypoxia adaptation mechanisms and (ii) different levels of IFNγ production in the 
HIF-1α absence. We could argue that the differences in bacterial numbers between WT and 
HIF-1α deficient mice could be due to low levels of IFNγ in the absence of HIF-1α. In fact, it 
has been previously shown, that IFNγ is involved in early and later protection against M. 
avium infection 38, 39. However, in our study, we did not observe significant differences in the 
production of IFNγ during infection in WT compared to HIF-1α deficient mice (data not 
shown). These results suggested that the differences in the bacterial numbers between WT 
and HIF-1α deficient mice were due to different levels of IFNγ production. Therefore, we 
hypothesize that exacerbation of infection in HIF-1α deficient mice mostly occurs in response 
to a failure in the control of bacterial growth caused by an interference of hypoxia adaptation 
mechanisms. The splenomegaly and hepatomegaly developed at latter time-points of M. 
avium infection reflect the increased recruitment of different types of immune cells 
respectively to the spleen and liver. In fact, a statistically significant increase in cell numbers 
from myeloid cell lineage, namely macrophages, neutrophils and DCs was found in infected 
HIF-1α deficient mice compared to WT mice, but that were not correlated with a better 
protection against M. avium infection. These observations are coincident with granuloma 
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necrosis occurrence in infected HIF-1α deficient mice but not in WT mice. This probably 
occurs due to an emergence of the immune system in response to inflammation. The 
granuloma disintegration leads to the release of virulent bacteria from dead macrophages, 
allowing bacteria to disseminate in the tissue spreading and infecting other tissues 6. 
Concerning the analysis of lymphocytes, a significant increase in the numbers of spleen T 
cells from infected HIF-1α deficient mice was found comparing to WT mice at later time-
points of infection. No differences were observed in the liver. Flórido et al have described, 
using M. avium aerosol infection of TNF deficient mice, the development of pulmonary 
granuloma disintegration that led to an extensive expansion of T cells and macrophages 55. It 
seems therefore, that besides T cells, also macrophages, DCs and neutrophils are 
determinant in the disintegration of the granuloma occurring in the liver in our study model. 
The Appelberg group has described a model of mycobacterial infection featuring the 
development of lesions containing causeous necrotic material. Additionally, the development 
of necrosis in this model required an intact type 1 immune axis 69. Interestingly, the 
phenotype resulting from the loss of HIF-1α in the myeloid cell lineage showed clear 
differences between WT and HIF-1α deficient mice. The results obtained in this work are 
consistent with previous findings showing that, WT mice intravenously infected with 100 
CFUs of M. avium 25291, developed granuloma with central necrosis after four months of 
infection 69. The morphometric analysis of liver sections at days 30 and 60 post-infection has 
shown small, but not significant differences, in the numbers of cellular infiltrates and in the 
percentage of infiltrated area in WT and HIF-1α deficient mice. Keeping in mind these 
results, the analysis of spleen or liver cellularity in generally showed equal numbers at earlier 
time-points of infection. In contrast, the bacterial numbers were significantly increased in HIF-
1α deficient mice compared to WT mice at these time-points of infection. In summary, at 
early stages of infection, the differences in bacterial burdens are not reflected either in 
cellularity or in the infiltrating area. Theoretically, the increase observed in the intracellular 
bacterial loads in the absence of HIF-1α at late stages of infection should reflect an 
accelerated necrotic death of infected macrophages in the granuloma and bacteria tissue 
dissemination 109, 131. This assumption was confirmed, since, the absence of HIF-1α led to an 
increase of cellular infiltrates, an increase of granuloma size and consequently an 
anticipation of necrosis. The increased size of granuloma suggests that augmented bacterial 
load led to increased numbers of heavily infected macrophages and other immune cells 
types. The lack of hypoxia adaptation mechanisms in macrophages leads to evident 
differences in the progression of M. avium infection. Here we provide evidence that HIF-1α 
plays a crucial role in the development of necrosis in this type of immunopathology.  
In conclusion, the work presented here gives a plausible explanation regarding the 
development of necrotic granulomas during M. avium infection. Altogether, we provide 
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evidences suggesting that granulomas are hypoxic before underging necrosis, through the 
analysis of vascularization and quantification of HIF-1α in a necrotizing mice model. Further, 
we used a mice model with a genetic ablation of the HIF-1α transcription factor in the 
myeloid lineage which clearly induces an impairment of the resistance against M. avium 
infection. All these data together show that hypoxia is one of the major causes in the 
progression to necrosis. This work indicates that by the manipulation or modulation of 
macrophage hypoxic adaptation during infection it might be possible to avoid pathology. 
 
Future perspectives 
 
The present work has shown that exacerbation of the M. avium infection and the 
onset of necrosis is a direct consequence of the lack of HIF-1α in myeloid cells. It has been 
also clear that macrophages adaptation to hypoxic conditions is crucial to the resistance 
against M. avium infection. To confirm this observation, we could perform in vitro studies 
using macrophages from a WT and HIF-1α deficient mice exposed to M. avium to quantified 
the bacterial load in both normoxia and hypoxia conditions. The activation of macrophages 
by IFNγ is a crucial step in the resistance against M. avium infection and different levels of 
IFNγ can lead to a profound impact in the activation of macrophages and consequently in the 
bacterial burdens. Since the macrophage activation is IFNγ-dependent, it is important to 
understand the role of IFNγ during the M. avium infection. During this work we only have 
observed the IFNγ production in later stages of the infection, since the necrosis occurs in late 
time-points of infection, however, we could perform an assay to quantify IFNγ in early time 
points of infection. 
Here we hypothesized that appearance of hypoxic regions at the center of granuloma 
occurs before the development of necrosis in M. avium infection. The appearance of hypoxic 
regions induces a cellular adaptation mechanism which is a HIF-1α-dependent process. 
Since the results showed an exacerbation of M. avium numbers in the absence of HIF-1α in 
myeloid cells, it would be interesting trying to control the bacterial burdens, using mice with 
HIF-1α over expressed. The lack of vascularization in the center of granuloma seems to be a 
crucial step in the development of necrosis either in WT or HIF-1α deficient mice. This 
process is mainly regulated by angiogenesis factors, namely VEGF. We could use mice with 
VEGF over expressed in order to try to increase the ability to re-vascularize and re-
oxygenate the center of the granuloma and consequently prevent the development of 
necrosis. On the other hand, we could use knockout mice for VEGF, which will probably 
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exacerbate the M. avium infection despite the ability of hypoxic adaptation in macrophages 
are intact. 
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